|
Market Closed -
NSE India S.E.
07:05:09 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 993.00 INR | +3.71% |
|
-0.08% | +10.29% |
Company Valuation: Strides Pharma Science Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 31,121 | 25,858 | 72,114 | 61,675 | 86,435 | 91,528 | - |
| Change | - | -16.91% | 178.88% | -14.47% | 40.15% | 5.89% | - |
| Enterprise Value (EV) | 31,121 | 25,858 | 72,114 | 61,675 | 86,435 | 91,528 | 91,528 |
| Change | - | -16.91% | 178.88% | -14.47% | 40.15% | 5.89% | 0% |
| P/E | -6.76x | -12.7x | -101x | 1.71x | 15.5x | 14.1x | 10x |
| PBR | 1.32x | 1.19x | 3.39x | - | 2.78x | 2.38x | 1.96x |
| PEG | - | 0.2x | 1.5x | -0x | -0.2x | 1.1x | 0.2x |
| Capitalization / Revenue | 1.01x | 0.7x | 1.78x | 1.35x | 1.78x | 1.57x | 1.32x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.57x | 1.32x |
| EV / EBITDA | -0x | 0x | 0x | 0x | 0x | 8.19x | 6.53x |
| EV / EBIT | -0x | 0x | 0x | - | 0x | 10.3x | 8.37x |
| EV / FCF | -0x | -0x | 0x | 0x | 0x | 19x | 13.9x |
| FCF Yield | -12.9% | -1.95% | 8.08% | 7.16% | 3.29% | 5.25% | 7.17% |
| Dividend per Share 2 | - | 1.5 | 2.5 | - | 5 | 3 | 3 |
| Rate of return | - | 0.52% | 0.32% | - | 0.53% | 0.31% | 0.31% |
| EPS 2 | -51.28 | -22.49 | -7.76 | 390.5 | 60.34 | 68.1 | 95.4 |
| Distribution rate | - | -6.67% | -32.2% | - | 8.29% | 4.41% | 3.14% |
| Net sales 1 | 30,702 | 36,884 | 40,511 | 45,653 | 48,587 | 58,230 | 69,123 |
| EBITDA 1 | -103.2 | 4,302 | 7,433 | 8,028 | 9,253 | 11,173 | 14,014 |
| EBIT 1 | -2,531 | 1,869 | 5,226 | - | 7,229 | 8,850 | 10,940 |
| Net income 1 | -4,602 | -2,026 | -706.1 | 35,935 | 5,562 | 6,277 | 8,798 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 346.60 | 286.35 | 784.70 | 669.20 | 937.75 | 957.50 | 957.50 |
| Nbr of stocks (in thousands) | 89,790 | 90,303 | 91,900 | 92,163 | 92,173 | 92,173 | - |
| Announcement Date | 5/24/22 | 5/25/23 | 5/22/24 | 5/22/25 | 5/18/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.06x | - | - | 0.31% | 923M | ||
| 35.06x | 6.57x | 22.78x | 0.9% | 47.69B | ||
| 18.39x | 2.19x | 9.92x | 1.41% | 39.96B | ||
| 27.68x | 3.36x | 17.43x | 0.91% | 12.02B | ||
| 26.48x | 3.79x | 15.72x | 0.61% | 11.53B | ||
| 18.73x | 3.33x | 11.58x | 3.85% | 9.18B | ||
| 9.03x | 2.08x | 5.42x | 4.46% | 7.53B | ||
| 16.02x | 2.09x | 6.8x | 3.19% | 7.29B | ||
| 27.32x | 3.56x | 16.55x | 0.17% | 6.63B | ||
| Average | 21.42x | 3.37x | 13.27x | 1.76% | 15.86B | |
| Weighted average by Cap. | 25.19x | 4.02x | 15.37x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- STAR Stock
- Valuation Strides Pharma Science Limited
Select your edition
All financial news and data tailored to specific country editions
















